Dupilumab for Eosinophilic Esophagitis With Severe Strictures
Clinical trial NCT06352073 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06352073
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-16
- Primary completion
- 2026-04-16
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.